EFFECTIVENESS OF COMPLETE AND EARLY VITRECTOMY FOR ACUTE POST-CATARACT ENDOPHTHALMITISVMNN
Main Article Content
Abstract
Purpose: To evaluate the efficacy and safety of complete and early vitrectomy for endophthalmitis (CEVE) in acute post-cataract endophthalmitis (APCE) and to identify predictors of treatment outcome. Methods: Uncontrolled clinical intervention conducted at Ho Chi Minh City Eye Hospital (Jan–Aug 2022). Thirty eyes from 30 patients with APCE ≤ 6 weeks after PHACO and visual acuity (VA) ≥ light perception but no red reflex underwent CEVE within 24 h of admission. LogMAR VA and vitreous haze (EVS scale) were assessed pre-operatively and at 1 week, 1 month and 3 months. Results: Mean age 60,7 ± 11,3 years; 73,3% male. Mean logMAR VA improved from 2,38 ± 0,16 to 0,63 ± 0,64 at 3 months (p < 0,0001); 66,7% achieved VA ≥ 0,5 and 76,7% VA ≥ 0,1. Vitreous haze improved to grade ≤ 2 in 90,0% of eyes. Overall (anatomic + functional) success was 76,7%. Positive culture rate 66,7%: coagulase-negative Staphylococcus 56,7%; Gram-negative 6,7%. Complications: macular pathology 20%, retinal detachment 6,7%, iris neovascularisation 3,3%. Shorter interval PHACO-symptom (p = 0,021) and poorer baseline VA (p = 0,035) predicted better outcomes. Conclusions: CEVE provides high anatomical and functional success with low complication rates in APCE. Early intervention and baseline vision are key determinants of prognosis.
Article Details
Keywords
Endophthalmitis; Early Complete Vitrectomy; Cataract Surgery; PHACO.
References
2. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravitreous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113(12):1479-1496.
3. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122(1):1-17.
4. Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3): 597-613.
5. Patel SN, Storey P, Pancholy M, et al. Changes in practice patterns for the management of endophthalmitis. Retina. 2019;39(4):718-724.
6. Dave VP, Pathengay A, Schwartz SG, Flynn HW Jr. Endophthalmitis following pars plana vitrectomy: a literature review of incidence, causative organisms, and treatment outcomes. Clin Ophthalmol. 2014;8:2183-2188.
7. Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008;115(9):1501-1507.
8. Maguire JI. Postoperative endophthalmitis: optimal management and the role and timing of vitrectomy surgery. Eye (Lond). 2008;22(10): 1290-1300.
9. Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina. 2005;25(2):208-211.
10. Bernard A, Bron AM, Creuzot-Garcher C, et al. Complete and early vitrectomy for endophthalmitis with good visual outcomes. Graefes Arch Clin Exp Ophthalmol. 2020;258(4): 845-850.